Cargando…
p19Arf sensitizes B16 melanoma cells to interferon-β delivered via mesenchymal stem cells in vitro
The immune stimulatory and anti-neoplastic functions of type I interferon have long been applied for the treatment of melanoma. However, the systemic application of high levels of this recombinant protein is often met with toxicity. An approach that provides localized, yet transient, production of t...
Autores principales: | Da-Costa, R.C., Vieira, I.L., Hunger, A., Tamura, R.E., Strauss, B.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025448/ https://www.ncbi.nlm.nih.gov/pubmed/32077463 http://dx.doi.org/10.1590/1414-431X20198876 |
Ejemplares similares
-
Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy
por: Hunger, Aline, et al.
Publicado: (2017) -
Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy
por: Medrano, Ruan F. V., et al.
Publicado: (2022) -
Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma()()
por: Catani, João Paulo Portela, et al.
Publicado: (2016) -
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death
por: Hunger, Aline, et al.
Publicado: (2017) -
Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer
por: Strauss, Bryan E, et al.
Publicado: (2018)